Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Corrigendum Open Access | 10.1172/jci.insight.167011

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans

Tatsunori Miyata, Xiaoqin Wu, Xiude Fan, Emily Huang, Carlos Sanz-Garcia, Christina K. Cajigas-Du Ross, Sanjoy Roychowdhury, Annette Bellar, Megan R. McMullen, Jaividhya Dasarathy, Daniela S. Allende, Joan Caballeria, Pau Sancho-Bru, Craig J. McClain, Mack Mitchell, Arthur J. McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, and Laura E. Nagy

Find articles by Miyata, T. in: PubMed | Google Scholar

Find articles by Wu, X. in: PubMed | Google Scholar

Find articles by Fan, X. in: PubMed | Google Scholar

Find articles by Huang, E. in: PubMed | Google Scholar

Find articles by Sanz-Garcia, C. in: PubMed | Google Scholar

Find articles by Ross, C. in: PubMed | Google Scholar

Find articles by Roychowdhury, S. in: PubMed | Google Scholar

Find articles by Bellar, A. in: PubMed | Google Scholar

Find articles by McMullen, M. in: PubMed | Google Scholar

Find articles by Dasarathy, J. in: PubMed | Google Scholar

Find articles by Allende, D. in: PubMed | Google Scholar

Find articles by Caballeria, J. in: PubMed | Google Scholar

Find articles by Sancho-Bru, P. in: PubMed | Google Scholar

Find articles by McClain, C. in: PubMed | Google Scholar

Find articles by Mitchell, M. in: PubMed | Google Scholar

Find articles by McCullough, A. in: PubMed | Google Scholar

Find articles by Radaeva, S. in: PubMed | Google Scholar

Find articles by Barton, B. in: PubMed | Google Scholar

Find articles by Szabo, G. in: PubMed | Google Scholar

Find articles by Dasarathy, S. in: PubMed | Google Scholar

Find articles by Nagy, L. in: PubMed | Google Scholar

Published December 8, 2022 - More info

Published in Volume 7, Issue 23 on December 8, 2022
JCI Insight. 2022;7(23):e167011. https://doi.org/10.1172/jci.insight.167011.
© 2022 Miyata et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published December 8, 2022 - Version history
View PDF

Related article:

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
Tatsunori Miyata, Xiaoqin Wu, Xiude Fan, Emily Huang, Carlos Sanz-Garcia, Christina K. Cajigas-Du Ross, Sanjoy Roychowdhury, Annette Bellar, Megan R. McMullen, Jaividhya Dasarathy, Daniela S. Allende, Joan Caballeria, Pau Sancho-Bru, Craig J. McClain, Mack Mitchell, Arthur J. McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, Laura E. Nagy
Tatsunori Miyata, Xiaoqin Wu, Xiude Fan, Emily Huang, Carlos Sanz-Garcia, Christina K. Cajigas-Du Ross, Sanjoy Roychowdhury, Annette Bellar, Megan R. McMullen, Jaividhya Dasarathy, Daniela S. Allende, Joan Caballeria, Pau Sancho-Bru, Craig J. McClain, Mack Mitchell, Arthur J. McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, Laura E. Nagy
Research Article Hepatology Inflammation

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans

  • Text
  • PDF
Abstract

Hepatocellular death contributes to progression of alcohol–associated (ALD-associated) and non–alcohol-associated (NAFL/NASH) liver diseases. However, receptor-interaction protein kinase 3 (RIP3), an intermediate in necroptotic cell death, contributes to injury in murine models of ALD but not NAFL/NASH. We show here that a differential role for mixed-lineage kinase domain–like protein (MLKL), the downstream effector of RIP3, in murine models of ALD versus NAFL/NASH and that RIP1-RIP3-MLKL can be used as biomarkers to distinguish alcohol-associated hepatitis (AH) from NASH. Phospho-MLKL was higher in livers of patients with NASH compared with AH or healthy controls (HCs). MLKL expression, phosphorylation, oligomerization, and translocation to plasma membrane were induced in WT mice fed diets high in fat, fructose, and cholesterol but not in response to Gao-binge (acute on chronic) ethanol exposure. Mlkl–/– mice were not protected from ethanol-induced hepatocellular injury, which was associated with increased expression of chemokines and neutrophil recruitment. Circulating concentrations of RIP1 and RIP3, but not MLKL, distinguished patients with AH from HCs or patients with NASH. Taken together, these data indicate that MLKL is differentially activated in ALD/AH compared with NAFL/NASH in both murine models and patients. Furthermore, plasma RIP1 and RIP3 may be promising biomarkers for distinguishing AH and NASH.

Authors

Tatsunori Miyata, Xiaoqin Wu, Xiude Fan, Emily Huang, Carlos Sanz-Garcia, Christina K. Cajigas-Du Ross, Sanjoy Roychowdhury, Annette Bellar, Megan R. McMullen, Jaividhya Dasarathy, Daniela S. Allende, Joan Caballeria, Pau Sancho-Bru, Craig J. McClain, Mack Mitchell, Arthur J. McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, Laura E. Nagy

×

Original citation: JCI Insight. 2021;6(4):e140180. https://doi.org/10.1172/jci.insight.140180

Citation for this corrigendum: JCI Insight. 2022;7(23):e167011. https://doi.org/10.1172/jci.insight.167011

Following the publication of this article, the authors became aware of similarities between the CYP2E1 blot in Figure 4A and the pEIF2A blot in Figure 4B. After reviewing the original data, the authors determined that the pEIF2A blot in Figure 4B was incorrect and that this error was caused by misidentification of pEIF2A after reprobing of the CYP2E1 membrane for pEIF2A, CHOP, and GRP78. The authors have provided a correct version of Figure 4B with data obtained from a repeated experiment. This correct version appears below.

Figure 4B

The authors regret the error.

Footnotes

See the related article at Differential role of MLKL in alcohol-associated and non-alcoholic fatty liver disease in mice and human.

Version history
  • Version 1 (December 8, 2022): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts